These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

828 related articles for article (PubMed ID: 26078430)

  • 1. Targeting FGFR Signaling in Cancer.
    Touat M; Ileana E; Postel-Vinay S; André F; Soria JC
    Clin Cancer Res; 2015 Jun; 21(12):2684-94. PubMed ID: 26078430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent developments and advances of FGFR as a potential target in cancer.
    Xue WJ; Li MT; Chen L; Sun LP; Li YY
    Future Med Chem; 2018 Sep; 10(17):2109-2126. PubMed ID: 30066580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances and challenges in targeting FGFR signalling in cancer.
    Babina IS; Turner NC
    Nat Rev Cancer; 2017 May; 17(5):318-332. PubMed ID: 28303906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting fibroblast growth factor receptor pathway in breast cancer.
    Criscitiello C; Esposito A; De Placido S; Curigliano G
    Curr Opin Oncol; 2015 Nov; 27(6):452-6. PubMed ID: 26397764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis.
    Ronca R; Giacomini A; Rusnati M; Presta M
    Expert Opin Ther Targets; 2015; 19(10):1361-77. PubMed ID: 26125971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathways: fibroblast growth factor signaling: a new therapeutic opportunity in cancer.
    Brooks AN; Kilgour E; Smith PD
    Clin Cancer Res; 2012 Apr; 18(7):1855-62. PubMed ID: 22388515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor receptor inhibitors as a cancer treatment: from a biologic rationale to medical perspectives.
    Dieci MV; Arnedos M; Andre F; Soria JC
    Cancer Discov; 2013 Mar; 3(3):264-79. PubMed ID: 23418312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast Growth Factor (FGF) Receptor/FGF Inhibitors: Novel Targets and Strategies for Optimization of Response of Solid Tumors.
    Hierro C; Rodon J; Tabernero J
    Semin Oncol; 2015 Dec; 42(6):801-19. PubMed ID: 26615127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the fibroblast growth factor receptor family in cancer.
    Hallinan N; Finn S; Cuffe S; Rafee S; O'Byrne K; Gately K
    Cancer Treat Rev; 2016 May; 46():51-62. PubMed ID: 27109926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGFR-TKI resistance in cancer: current status and perspectives.
    Yue S; Li Y; Chen X; Wang J; Li M; Chen Y; Wu D
    J Hematol Oncol; 2021 Feb; 14(1):23. PubMed ID: 33568192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGFR-targeted therapeutics for the treatment of breast cancer.
    De Luca A; Frezzetti D; Gallo M; Normanno N
    Expert Opin Investig Drugs; 2017 Mar; 26(3):303-311. PubMed ID: 28121208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De-regulated FGF receptors as therapeutic targets in cancer.
    Knights V; Cook SJ
    Pharmacol Ther; 2010 Jan; 125(1):105-17. PubMed ID: 19874848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale for targeting fibroblast growth factor receptor signaling in breast cancer.
    André F; Cortés J
    Breast Cancer Res Treat; 2015 Feb; 150(1):1-8. PubMed ID: 25677745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting fibroblast growth factor receptor signaling in hepatocellular carcinoma.
    Cheng AL; Shen YC; Zhu AX
    Oncology; 2011; 81(5-6):372-80. PubMed ID: 22269894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting FGF receptors in colorectal cancer: from bench side to bed side.
    Abdel-Rahman O
    Future Oncol; 2015; 11(9):1373-9. PubMed ID: 25952783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of fibroblast growth factor receptor (FGFR) protein-tyrosine kinase inhibitors in the treatment of cancers including those of the urinary bladder.
    Roskoski R
    Pharmacol Res; 2020 Jan; 151():104567. PubMed ID: 31770593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting mutant fibroblast growth factor receptors in cancer.
    Greulich H; Pollock PM
    Trends Mol Med; 2011 May; 17(5):283-92. PubMed ID: 21367659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting FGFR for cancer therapy.
    Zhang P; Yue L; Leng Q; Chang C; Gan C; Ye T; Cao D
    J Hematol Oncol; 2024 Jun; 17(1):39. PubMed ID: 38831455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Drugs Against Fibroblast Growth Factor(s)-Induced Cell Signaling.
    Agrawal S; Maity S; AlRaawi Z; Al-Ameer M; Kumar TKS
    Curr Drug Targets; 2021; 22(2):214-240. PubMed ID: 33045958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer molecules targeting fibroblast growth factor receptors.
    Liang G; Liu Z; Wu J; Cai Y; Li X
    Trends Pharmacol Sci; 2012 Oct; 33(10):531-41. PubMed ID: 22884522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.